Limbaroc, Jenny A.
HRN: 26-25-33 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/23/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
11/23/2024
11/30/2024
IV
500mg
500mg Every 8 Hrs X 7 Days
Primary Cs
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes